Met-Lys-bradykinin [5113]



Met-Lys-bradykinin


SMILES CSCC[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCN=C(N)N)C(=O)O
InChIKey SSXPFNXUSFJJEI-BHEJXMHWSA-N
Sequence MKRPPGFSPFR
HELM PEPTIDE1{M.K.R.P.P.G.F.S.P.F.R}$$$$

Chemical Properties

Hydrogen bond acceptors 17
Hydrogen bond donors 15
Rotatable bonds 38
Log P -4.137
Molecular weight (Da) 1318.7
Stereochemistry info unspecified

Database connections

Model (AF2) B1 B2


No bioactivity data available.

Met-Lys-bradykinin


Drug properties

Molecular type Peptide
Physiological/Surrogate Surrogate
Approved drug No

Distribution across phases (no. indications)

Phase I 0
Phase II 0
Phase III 0
Phase IV 0

Database connections

Model (AF2) B1 B2


Compound is not listed as a drug.